Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Cangene Corporation

ClinicalTrials.gov Identifier:

NCT00722332

First received: July 23, 2008

Last updated: October 30, 2013

Last verified: October 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2013
Primary Completion Date:	October 2013 (Final data collection date for primary outcome measure)